Cargando…

First-line treatment of ovarian cancer: questions and controversies to address

Detalles Bibliográficos
Autor principal: Ledermann, Jonathan A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5898654/
https://www.ncbi.nlm.nih.gov/pubmed/29662548
http://dx.doi.org/10.1177/1758835918768232
_version_ 1783314160239509504
author Ledermann, Jonathan A.
author_facet Ledermann, Jonathan A.
author_sort Ledermann, Jonathan A.
collection PubMed
description
format Online
Article
Text
id pubmed-5898654
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher SAGE Publications
record_format MEDLINE/PubMed
spelling pubmed-58986542018-04-16 First-line treatment of ovarian cancer: questions and controversies to address Ledermann, Jonathan A. Ther Adv Med Oncol Editorial SAGE Publications 2018-04-11 /pmc/articles/PMC5898654/ /pubmed/29662548 http://dx.doi.org/10.1177/1758835918768232 Text en © The Author(s), 2018 http://www.creativecommons.org/licenses/by-nc/4.0/ This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 License (http://www.creativecommons.org/licenses/by-nc/4.0/) which permits non-commercial use, reproduction and distribution of the work without further permission provided the original work is attributed as specified on the SAGE and Open Access pages (https://us.sagepub.com/en-us/nam/open-access-at-sage).
spellingShingle Editorial
Ledermann, Jonathan A.
First-line treatment of ovarian cancer: questions and controversies to address
title First-line treatment of ovarian cancer: questions and controversies to address
title_full First-line treatment of ovarian cancer: questions and controversies to address
title_fullStr First-line treatment of ovarian cancer: questions and controversies to address
title_full_unstemmed First-line treatment of ovarian cancer: questions and controversies to address
title_short First-line treatment of ovarian cancer: questions and controversies to address
title_sort first-line treatment of ovarian cancer: questions and controversies to address
topic Editorial
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5898654/
https://www.ncbi.nlm.nih.gov/pubmed/29662548
http://dx.doi.org/10.1177/1758835918768232
work_keys_str_mv AT ledermannjonathana firstlinetreatmentofovariancancerquestionsandcontroversiestoaddress